Lumpectomy and tamoxifen use resulted in a significantly higher mFSFI than those with AI use (29.4 versus 23.7, p = 0.005). For patients who had mastectomy with reconstruction and reported AI use, mFSFI was significantly lower than those on no endocrine therapy (18.1 versus 29.6, p < 0.0001).